## Abstract **Paul Preissner** provides a typological prototype for the protocell, the Protocell Tower. Does it, however, already look familiar? Though a breathtaking chemical innovation, could protocell technology actually be behind the curve of architecture? Could it be that architects have alrea
Glucocorticoids and rheumatoid arthritis: Back to the future?
β Scribed by Larry W. Moreland; James R. O'Dell
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 91 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
MHC Ο major histocompatibility complex; ICAM-1 Ο intercellular adhesion molecule 1; ELAM-1 Ο endothelial leukocyte adhesion molecule 1; TNF Ο tumor necrosis factor; IL-1 Ο interleukin-1; COX-2 Ο cyclooxygenase 2; NF-B Ο nuclear factor B; IFNβ₯ Ο interferon-β₯; GM-CSF Ο granulocytemacrophage colony-stimulating factor; TIMP Ο tissue inhibitor of metalloproteinase; PIIINP Ο N-propeptide of type III procollagen. * DMARD Ο disease-modifying antirheumatic drug; DB Ο double blind; RCT Ο randomized controlled trial; MTX
π SIMILAR VOLUMES
## Abstract ## Objective Glucocorticoids are suspected to cause atherosclerosis. Because of the possibility that their antiinflammatory effect may be antiatherogenic, this study investigated the effect of glucocorticoids on the arteries of patients with rheumatoid arthritis (RA). ## Methods We a
## Abstract ## Objective To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA). ## Methods A total of 603 adult residents of Rochester, Minnesota with incident RA between 1955 and 1995 were followed up through thei